7733 logo

Olympus Corporation Stock Price

TSE:7733 Community·JP¥1.9t Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

7733 Share Price Performance

JP¥1,753.50
47.00 (2.75%)
JP¥1,819.23
Fair Value
JP¥1,753.50
47.00 (2.75%)
3.6% undervalued intrinsic discount
JP¥1,819.23
Fair Value
Price JP¥1,753.50
AnalystConsensusTarget JP¥1,819.23
AnalystLowTarget JP¥1,600.00
AnalystHighTarget JP¥2,300.00

7733 Community Narratives

·
Fair Value JP¥1.82k 3.6% undervalued intrinsic discount

7733: Market Will Weigh Product Recall Against Modest Guidance Revision Risk

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value JP¥1.6k 9.6% overvalued intrinsic discount

Austerity Policies And FDA Alerts Will Trigger Price Erosion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value JP¥2.3k 23.8% undervalued intrinsic discount

Digital And Robotic Endoscopy Will Serve A Growing Aging Market

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
JP¥2.3k
23.8% undervalued intrinsic discount
Revenue
5.87% p.a.
Profit Margin
13.45%
Future PE
14.83x
Price in 2029
JP¥2.7k
JP¥1.6k
9.6% overvalued intrinsic discount
Revenue
3.33% p.a.
Profit Margin
9.76%
Future PE
17.68x
Price in 2029
JP¥1.88k
JP¥1.82k
3.6% undervalued intrinsic discount
Revenue
3.91% p.a.
Profit Margin
10.92%
Future PE
18.3x
Price in 2029
JP¥2.16k

Trending Discussion

Updated Narratives

7733 logo

7733: New Management And Capital Returns Will Support Future Upside Potential

Fair Value: JP¥2.3k 23.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
7733 logo

7733: New Leadership And Capital Returns Will Likely Support Fairly Valued Shares

Fair Value: JP¥1.6k 9.6% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
7733 logo

7733: Future Returns Will Reflect Imaging Platform Adoption And Higher Dividend

Fair Value: JP¥1.82k 3.6% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

3 Risks
2 Rewards

Olympus Corporation Key Details

JP¥1.0t

Revenue

JP¥356.6b

Cost of Revenue

JP¥654.1b

Gross Profit

JP¥585.9b

Other Expenses

JP¥68.2b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 07, 2026
64.18
64.72%
6.75%
29.5%
View Full Analysis

About 7733

Founded
1919
Employees
28138
CEO
Robert John White
WebsiteView website
www.olympus.co.jp

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Recent 7733 News & Updates

Narrative Update Jun 29

7733: New Management And Capital Returns Will Support Future Upside Potential

Analysts have raised the Olympus price target to ¥2,300 from ¥2,214.53, citing updated assumptions on growth, margins and P/E in light of recent research on the impact of the refreshed management team. What’s in the News for Olympus Olympus announced a federal healthcare facility distribution agreement with First Nation Group, a Service-Disabled Veteran-Owned Small Business distributor.

Recent updates

No updates